The current status of biomarkers for predicting toxicity

INTRODUCTION: There are significant rates of attrition in drug development. A number of compounds fail to progress past preclinical development due to limited tools that accurately monitor toxicity in preclinical studies and in the clinic. Research has focused on improving tools for the detection of...

詳細記述

保存先:
書誌詳細
主要な著者: Campion, Sarah, Aubrecht, Jiri, Boekelheide, Kim, Brewster, David W, Vaidya, Vishal S, Anderson, Linnea, Burt, Deborah, Dere, Edward, Hwang, Kathleen, Pacheco, Sara, Saikumar, Janani, Schomaker, Shelli, Sigman, Mark, Goodsaid, Federico
フォーマット: Artigo
言語:Inglês
出版事項: 2013
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3870154/
https://ncbi.nlm.nih.gov/pubmed/23961847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/17425255.2013.827170
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料